Narcolepsy Market Size, Scope, and Share by 2027
Narcolepsy Market: Strategic Insights
Narcolepsy Market
-
CAGR (2018 - 2027)9.5% -
Market Size 2018
US$ 2.03 Billion -
Market Size 2027
US$ 4.54 Billion
Market Dynamics
GROWTH DRIVERS
- Increase in the prevalence of sleep disorders
- Growing awareness of narcolepsy symptoms
FUTURE TRENDS
- Development of personalized treatment plans
- Increase in adoption of cognitive-behavioral therapy
OPPORTUNITIES
- Growth in narcolepsy diagnostic services
- Expansion in treatment options
Key Players
- Bioprojet
- Teva Pharmaceutical Industries Ltd
- Jazz Pharmaceuticals Inc
- Graymark Healthcare Inc
- Arena Pharmaceuticals Inc
- Shire Acquired by Takeda
- Ligand Pharmaceuticals Inc
- Novartis AG
- Mylan N V
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Narcolepsy
Product
- Central Nervous System Stimulants
- Sodium Oxybate
- Antidepressants
Distribution Channel
- Hospital Pharmacies and Retail Pharmacies